FDA approves women's libido drug with strong warning

August 18, 2015 11:24 PM

29 0

NEW YORK A controversial drug to treat low sexual desire in women won approval from the Food and Drug Administration on Tuesday, but with a warning that about potentially dangerous side effects.

The FDA has twice rejected the drug, flibanserin, made by privately held Sprout Pharmaceuticals. Its latest decision comes after an advisory panel concluded in June the drug should be approved with strict measures in place to ensure patients are fully aware of the risks.

Also read: National Cancer Institute Says Researchers Didn’t Quickly Tell FDA After Two Deaths in a Lymphoma Study

Read more

To category page